Lee Molly M, Peterson Blake R
Department of Medicinal Chemistry, The University of Kansas , 2034 Becker Drive, Lawrence, Kansas 66047, United States.
ACS Omega. 2016 Dec 31;1(6):1266-1276. doi: 10.1021/acsomega.6b00356. Epub 2016 Dec 19.
We report a new method to quantify the affinity of small molecules for proteins. This method is based on Förster resonance energy transfer (FRET) between endogenous tryptophan (Trp) residues and the coumarin-derived fluorophore Pacific Blue (PB). Tryptophan residues are frequently found in proteins near ligand-binding sites, making this approach potentially applicable to a wide range of systems. To improve access to PB, we developed a scalable multigram synthesis of this fluorophore, starting with inexpensive 2,3,4,5-tetrafluorobenzoic acid. This route was used to synthesize fluorescent derivatives of biotin, as well as lower affinity thiobiotin, iminobiotin, and imidazolidinethione analogues that bind the protein streptavidin. Compared with previously published FRET acceptors for tryptophan, PB proved to be superior in both sensitivity and efficiency. These unique properties of PB enabled direct quantification of dissociation constants () as well as competitive inhibition constants () in the micromolar to nanomolar range. In comparison to analogous binding studies using fluorescence polarization, fluorescence quenching, or fluorescence enhancement, affinities determined using Trp-FRET were more precise and accurate as validated using independent isothermal titration calorimetry studies. FRET between tryptophan and PB represents a new tool for the characterization of protein-ligand complexes.
我们报告了一种量化小分子与蛋白质亲和力的新方法。该方法基于内源性色氨酸(Trp)残基与香豆素衍生的荧光团太平洋蓝(PB)之间的荧光共振能量转移(FRET)。色氨酸残基经常出现在蛋白质中靠近配体结合位点的位置,这使得该方法有可能适用于广泛的系统。为了更方便地获得PB,我们开发了一种可扩展的多克级合成这种荧光团的方法,从廉价的2,3,4,5-四氟苯甲酸开始。该路线用于合成生物素的荧光衍生物,以及与蛋白质抗生物素蛋白结合的低亲和力硫代生物素、亚氨基生物素和咪唑烷硫酮类似物。与先前发表的用于色氨酸的FRET受体相比,PB在灵敏度和效率方面都更具优势。PB的这些独特性质使得能够直接定量微摩尔到纳摩尔范围内的解离常数()以及竞争性抑制常数()。与使用荧光偏振、荧光猝灭或荧光增强的类似结合研究相比,使用Trp-FRET测定的亲和力经独立的等温滴定量热法研究验证后更加精确和准确。色氨酸与PB之间的FRET代表了一种表征蛋白质-配体复合物的新工具。